Dan Greenberg, PhD

home / authors / dan-greenberg-phd

Articles

April 7th 2010

Low-Value Services in Value-Based Insurance Design

Peter J. Neumann, ScD Hannah R. Auerbach, BA Joshua T. Cohen, PhD Dan Greenberg, PhD

Building negative incentives into value-based insurance design programs to discourage use of low-value care will involve a number of challenges.

September 7th 2009

Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?

Allison B. Rosen, MD, MPH, ScD Alicen B. Spaulding, MPH Dan Greenberg, PhD Jennifer A. Palmer, MS Peter J. Neumann, ScD

A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.

January 1st 2006

Do Drug Formulary Policies Reflect Evidence of Value?

Peter J. Neumann, ScD Pei-Jung Lin, MS Dan Greenberg, PhD Marc L. Berger, MD Steven M. Teutsch, MD Edward Mansley, PhD Milton C. Weinstein, PhD Allison B. Rosen, MD, ScD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Glaucoma | Image credit: Alessandro Grandini - stock.adobe.com

Published: November 21st 2024 | Updated: November 23rd 2024

Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions